中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2012, Vol. 47 Issue (5) :387-390     DOI:
ҩ�����ٴ� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << | >>
��������صĽṹ�����ڹǹؽ��������е�Ӧ��
������1������2��������2
1. ��̨���������ɷ����޹�˾��ɽ�� ��̨ 264006��2. ɽ��ʡҩѧ��ѧԺ������ 250101
Download: PDF (1406KB)   HTML (0KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ�� ������������أ�CS���Ľṹ�����ڹǹؽ��ף�OA���е�Ӧ�á����� ͨ�������������ף���ϱ���ʵ������������ͷ������������� CS�ṹ���и߶ȵIJ���һ�ԡ���ŷ�ޣ�CS���Ƽ�Ϊ����OA��֢״������ҩ���������CS��Ҫ�������OA����ʳ�������CS�Թؽ���ǵ��޸��ͱ������ã��������ܴٽ����ϸ���ĺϳɴ�л���ܣ� �ٽ�ϸ������ʣ�ECM���ṹ��ֵĺϳɡ����£�ͬʱ���Ʒֽ��л���ܣ�����ø��ECM��ֵĽ������á�
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
�ؼ����� ���������   ����Ƥ����   �ǰ�����   �ǹؽ���     
Abstract��
Keywords��   
�ո�����: 2011-09-18;
���߼��: �����ۣ��У��߼�����ʦ �о���������ҩ��Ŀ��� Tel����0755��82973708 E-mail��zhouxionghe@163.com
���ñ���:   
.��������صĽṹ�����ڹǹؽ��������е�Ӧ��[J]  �й�ҩѧ��־, 2012,V47(5): 387-390
.Structure of Chondroitin Sulfate and Its Application in Osteoarthritis Therapy[J]  Chinese Pharmaceutical Journal, 2012,V47(5): 387-390
��
[1] YAMADA S�� SUGAHARA K. Potential therapeutic application of chondroitin sulfate/dermatan sulfate[J]. Curr Drug Discov Technol�� 2008�� 5(4)�� 289-301. [2] MALAVAKI C�� MIZUMOTO S�� KARAMANOS N�� et al. Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease[J]. Connect Tissue Res�� 2008�� 49(3)��133-139. [3] VOLPI N. Analytical aspects of pharmaceutical grade chondroitin sulfates[J]. J Pharm Sci�� 2007�� 96(12)�� 3168-3180. [4] WINKELMAYER W C�� WAIKAR S S�� MOGUN H�� et al. Nonselective and cyclooxygenase- 2-selective NSAIDs and acute kidney injury[J]. Am J Med�� 2008�� 121(12)��1092-1098. [5] HOCHBERG M C�� CLEGG D O. Potential effects of chondroitin sulfate on joint swelling�� a GAIT report[J]. Osteoarthritis Cartilage�� 2008�� 16(suppl 3)�� 22-24. [6] MCCARTHY G�� O'DONOVAN J�� JONES B�� et al. Randomised double-blind�� positive- controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis[J]. Vet J�� 2007�� 174(1)�� 54-61. [7] HOCHBERG M C. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis�� an updated meta-analysis of randomized placebo-controlled trials of 2-year duration[J]. Osteoarthritis Cartilage�� 2010�� 18(suppl 1)�� 28-31. [8] MONFORT J�� MARTEL-PELLETIER J�� PELLETIER J P. Chondroitin sulphate for symptomatic osteoarthritis�� critical appraisal of meta-analyses[J]. Curr Med Res Opin�� 2008�� 24(5)�� 1303-1308. [9] MICHEL B A�� STUCKI G�� FREY D�� et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee�� a randomized�� controlled trial[J]. Arthritis Rheum�� 2005�� 52(3)�� 779-786. [10] UEBELHART D�� MALAISE M�� MARCOLONGO R�� et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate�� a one-year�� randomized�� double-blind�� multicenter study versus placebo[J]. Osteoarthritis Cartilage�� 2004��12(4)�� 269-276. [11] UEBELHART D�� THONAR E J�� DELMAS P D�� et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis�� a pilot study[J]. Osteoarthritis Cartilage�� 1998�� 6 (suppl A)�� 39-46. [12] VOLPI N. Chondroitin Sultate: Structure, Role and Pharmacological Activity[M]. Amsterdam: academic Press, 2006�� 475-488.[13] VERBRUGGEN G�� GOEMAERE S�� VEYS E M. Chondroitin sulfate�� S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA[J]. Osteoarthritis Cartilage�� 1998�� 6 (suppl A)�� 37-38. [14] VERBRUGGEN G�� GOEMAERE S�� VEYS E M. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs[J]. Clin Rheumatol�� 2002�� 21(3)�� 231-243. [15] JORDAN K M�� ARDEN N K�� DOHERTY M�� et al. EULAR Recommendations 2003�� an evidence based approach to the management of knee osteoarthritis�� report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)[J]. Ann Rheum Dis�� 2003�� 62(12)�� 1145-1155. [16] CLEGG D O�� REDA D J�� HARRIS C L�� et al. Glucosamine�� chondroitin sulfate�� and the two in combination for painful knee osteoarthritis[J]. N Engl J Med�� 2006�� 354(8)�� 795-808. [17] REICHENBACH S�� STERCHI R�� SCHERER M�� et al. Meta-analysis�� chondroitin for osteoarthritis of the knee or hip[J]. Ann Intern Med�� 2007�� 146(8)�� 580-590. [18] VOLPI N. Chondroitin Sulfate�� Structure�� Role and Pharmacological Activity[M]. Amsterdam�� Academic Press�� 2006�� 403. [19] RONCA G, CONTE A. Metabolic fate of partially depolymerized shark chondroitin sulfate in man[J]. Int J Clin Pharmacol Res�� 1993, 13��Suppl����27-34.[20] CONTE A, PALMIERI L, SEGNINI D, et al. Metabolic fate of partially depolimerized chondroitin sulfate administered to the rat[J]. Drugs Exp Clin Res�� 1991�� 17��1����27-33.[21] SAKAI S�� ONOSE J�� NAKAMURA H�� et al. Pretreatment procedure for the microdetermination of chondroitin sulfate in plasma and urine[J]. Anal Biochem�� 2002�� 302(2)��169-174. [22] WRENSHALL L E�� STEVENS R B�� CERRA F B�� et al. Modulation of macrophage and B cell function by glycosaminoglycans[J]. J Leukoc Biol�� 1999�� 66(3)�� 391-400. [23] PECCHI E�� PRIAM S�� MLADENOVIC Z�� et al. A potential role of chondroitin sulfate on bone in osteoarthritis�� inhibition of prostaglandin E(2) and matrix metalloproteinases synthesis in interleukin-1��-stimulated osteoblasts[J]. Osteoarthritis Cartilage�� 2012�� 20��2����127-135.[24] AIGNER T�� SOEDER S�� HAAG J. IL-1beta and BMPs-interactive players of cartilage matrix degradation and regeneration[J]. Eur Cell Mater�� 2006��12�� 49-56. [25] SAWITZKE A D�� SHI H�� FINCO M F�� et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis�� a report from the glucosamine/chondroitin arthritis intervention trial[J]. Arthritis Rheum�� 2008�� 58(10)�� 3183-3191. [26] MESSIER S P�� MIHALKO S�� LOESER R F�� et al. Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis�� a preliminary study[J]. Osteoarthritis Cartilage�� 2007�� 15(11)�� 1256-1266. [27] GABAY C�� MEDINGER-SADOWSKI C�� GASCON D�� et al. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis�� a randomized�� double-blind�� placebo-controlled clinical trial at a single center[J]. Arthritis Rheum�� 2011�� 63(11)�� 3383-3391. [28] WILDI L M�� RAYNAULD J P�� MARTEL-PELLETIER J�� et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy�� a randomised�� double-blind�� placebo-controlled pilot study using MRI[J]. Ann Rheum Dis�� 2011�� 70(6)��982-989.
[1] �����ã��������£�÷���.���Ǵ�л����ѧ�о��Ľ�չ[J]. �й�ҩѧ��־, 2012,47(8): 573-576
[2] ����Ƽ �ں��� ����� ����ϼ ���ۺ�.����������ƺ����ⶨ�ù��Ҷ���Ʒ������[J]. �й�ҩѧ��־, 2012,47(3): 236-
[3] ����ѧ �򲳽� ���� �½�Ӣ ��ѧƽ ������ ¬���.͸�������ڹǿ��е�Ӧ��[J]. �й�ҩѧ��־, 2012,47(3): 161-165
[4] �ƽ��� �Ž��� ���Ʒ� �ŷ ������ �ⶫ�� �콨�� ������ ������ ��˫�� ���.��������Ƭ����ϥ�ǹؽ��׵Ģ��ڶ��������˫ä�ٴ�����[J]. �й�ҩѧ��־, 2011,46(22): 1740-1745
[5] ��� ½��� ̷�� ����.��Чëϸ�ܵ�Ӿ��ͬʱ���������������[J]. �й�ҩѧ��־, 2010,45(15): 1179-1181
[6] �����ɣ���ѧ�����޶�����ݣ������壬���� . HPLC-DAD ͬʱ�ⶨ������ά������Һ�� 3 �ֻ��Գɷֵĺ���[J]. �й�ҩѧ��־, 2009,44(21): 1669-1672
[7] ������;�;������;���촻;������.�ǰ������������ڰ����ĺ�Ĭ�������е�ǰ��[J]. �й�ҩѧ��־, 2008,43(23): 1761-1764
[8] ������;������;������;��ԣǿ.�ȱ�ȹ���ǰ����ǶԸ�����ECV-304���˵ı�������[J]. �й�ҩѧ��־, 2008,43(18): 1394-1398
[9] ������;����;������;��Ӣ;����;����.�ο��ȱ��ǰ����Ƕ�bFGF�յ���Ѫ��ƽ����ϸ����ֳ��ԭ������<>ic-myc mRNA����Ӱ��[J]. �й�ҩѧ��־, 2007,42(22): 1714-1716
[10] ���ؾ�;����;�︣��;������.�ȱ��ǰ����ǶԾ���ϸ�����ܶ�֬�����������Ӱ��[J]. �й�ҩѧ��־, 2007,42(03): 184-186
[11] ��ε;��ʤ��;������.�ǰ����Ƕ�����ϸ���������Ӽ���鵼��Ras/MAPK�ź�ת��ͨ·�ĵ��ڻ���[J]. �й�ҩѧ��־, 2006,41(23): 1767-1770
[12] ��ʤ��;����;�ź���.����Ƥ���������P��ڷ��Ƽ���Ѫ˨�����о�[J]. �й�ҩѧ��־, 2006,41(17): 1316-1319
[13] �Ž�;����;������;�����.�ȱ��ǰ����Ƕ����������˵���Ƥϸ�����ܵ�Ӱ��[J]. �й�ҩѧ��־, 2006,41(13): 990-992
[14] ӡ����;����ѧ;����ɽ;������.����֬������IJ��������Ƽ����ùǹؽ��׵�Ӱ��[J]. �й�ҩѧ��־, 2006,41(06): 424-426
[15] ����;��ʤ��.�ǰ�������ϸ���ź�ת���Ĺ�ϵ[J]. �й�ҩѧ��־, 2005,39(17): 1285-1288
Copyright 2010 by �й�ҩѧ��־